Nikoskelainen E K, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus M L
Department of Ophthalmology, University of Turku, Finland.
Ophthalmology. 1996 Mar;103(3):504-14. doi: 10.1016/s0161-6420(96)30665-9.
Leber hereditary optic neuropathy (LHON) is associated with primary and secondary mutations in mitochondrial DNA. Clinical studies suggest that there is a wide spectrum of clinical expression.
Fifty-three affected and 131 unaffected maternal relatives from 21 pedigrees with LHON were studied neuro-ophthalmologically and followed over a period of 14 years. Mitochondrial DNA analysis was performed on their blood specimens.
Thirty-two affected (60%) individuals from ten families harbored the 11778 mutation and ten individuals (19%) from three families harbored the 3460 mutation. No confirmed primary mutation was detected in 11 (21%) affected individuals from eight families. The visual outcome was better in families with the 3460 mutation than in those with the 11778 mutation. Secondary mutations did not affect the penetrance or the visual outcome. Fifteen patients had a favorable outcome; seven of whom had subclinical disease, two had slowly progressive LHON with a favorable visual outcome, and six had classic LHON with spontaneous recovery. In seven patients, the onset of the disease had been in childhood. These patients had a more favorable prognosis than the adults. Results of eye examinations of asymptomatic maternal relatives showed subclinically affected individuals.
In addition to classic LHON, the disease can manifest itself in three different atypical forms: subclinical disease, slowly progressive LHON with a favorable visual outcome, and LHON with the classic acute stage but spontaneous visual recovery. The current study suggests that the ophthalmologic findings and outcome in LHON are independent of secondary mutations.
Leber遗传性视神经病变(LHON)与线粒体DNA的原发性和继发性突变相关。临床研究表明,其临床表型范围广泛。
对来自21个LHON家系的53名患病和131名未患病的母系亲属进行神经眼科检查,并随访14年。对他们的血液样本进行线粒体DNA分析。
来自10个家系的32名患病个体(60%)携带11778突变,来自3个家系的10名个体(19%)携带3460突变。在来自8个家系的11名患病个体(21%)中未检测到确诊的原发性突变。携带3460突变的家系的视觉预后比携带11778突变的家系更好。继发性突变不影响外显率或视觉预后。15名患者预后良好;其中7名有亚临床疾病,2名患有缓慢进展性LHON但视觉预后良好,6名患有典型LHON且自发恢复。7名患者在儿童期发病。这些患者的预后比成年人更有利。无症状母系亲属的眼部检查结果显示有亚临床受累个体。
除了典型的LHON,该病还可表现为三种不同的非典型形式:亚临床疾病、缓慢进展性LHON且视觉预后良好、以及具有典型急性期但自发视觉恢复的LHON。当前研究表明,LHON的眼科检查结果和预后与继发性突变无关。